Navigation Links
Insmed Announces First Quarter 2011 Financial Results
Date:5/10/2011

nce of $104.9 million, which will continue to drive our development of ARIKACE®."

Financial Results:For the first quarter of 2011, Insmed posted a net loss attributable to common stockholders of $16.1 million, or $0.85 per share – basic and diluted, compared to net income of 0.1 million, or $0.01 per share – basic and diluted, for the three months ended March 31, 2010.  The net loss attributable to common stockholders in 2011 includes the conversion of the Series B Conditional Convertible Preferred Stock, and a non-cash charge for the beneficial conversion feature of the Series B Preferred Stock in the amount of $9.2 million.  When issuing debt or equity securities that are convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity financing is committed, a company is required to record a beneficial conversion feature ("BCF") charge in accordance with Accounting Standards Codification 470-20.  This BCF of $9.2 million reduced net income available to holders of our common shares and, in turn, reduced our earnings per common share on a basic and diluted basis, by $0.48.  The charge represents the $1.00 difference between the conversion price of the preferred stock of $7.10 per share and its carrying value of $6.10 per share.  The carrying value of the preferred stock was based on its fair value at issuance, which was estimated using the common stock price reduced for a lack of marketability between the issuance date and the anticipated date of conversion.

Revenues were $1.6 million, as compared to $1.9 million for the quarter ended March 31, 2010.  The reduction in revenue was primarily attributable to $0.6 million in lower cost recovery from our IPLEX™ Expanded Access Program in Europe, which was partially offset by $0.3 million in licensing fees received during the most recent quarter.  The reduced IPLEX™ cost recovery was due to t
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Insmed to Host 2011 First Quarter Earnings Conference Call
2. Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
3. One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective
4. Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split
5. Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call
6. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
7. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
8. Insmed to Host Third Quarter 2010 Conference Call
9. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
10. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
11. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 LUNGevity Foundation, the nation,s leading ... Administration,s (FDA) approval of Bristol Myers Squibb,s new ... treatments add another critical new treatment option to ... a patient,s own immune system to fight cancerous ... for patients with squamous cell lung cancer, a ...
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "India Pharma Outlook 2015: Accelerating growth to the ... Generics" report to their offering. ... in the 2013 caused by the market,s reaction to ... expected to continue to be healthy, as the momentum ...
(Date:3/5/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/gl7m98/japan_pharma ... Pharma Outlook 2015: Year to Watch out for Authorized ... to their offering. The new pricing ... April -2014 (Annexure 1) is a game changer initiative. ... or innovator. The most of the companies are revalidating ...
Breaking Medicine Technology:LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3
(Date:3/5/2015)... For PASCHA Chocolate, less is more. ... the robust flavor of the cacao bean bursts through ... is free from peanuts, nuts, dairy, soy, eggs, fish, ... 6th- 8th at Expo West., ,    NEW PASCHA ... broken new ground with their New PASCHA Make Me ...
(Date:3/5/2015)... Minn. (PRWEB) March 05, 2015 ... invites healthcare organizations to participate in its 2015 ... data from executive and director-level positions, and the ... , Last year’s report featured data on 60 ... independent children’s healthcare organizations and 7 subsidiary children’s ...
(Date:3/5/2015)... March 05, 2015 Leading nutritional supplement ... week’s Arnold Sports Festival and Arnold Fitness EXPO ... Metabolic Nutrition will host a display booth featuring free ... E.S.P. and its highly-popular, class-leading fat burner Synedrex. The ... unique recipes that utilize its top-of-the-line supplements and miniature ...
(Date:3/5/2015)... Indialantic, FL (PRWEB) March 05, 2015 ... sports nutrition products, is pleased to offer reformulated Millennium ... official website, Millennium 500 is a German grade creatine ... muscle hydration, promote muscle recovery, and aid with overall ... occurring compound that acts as a reserve energy source ...
(Date:3/5/2015)... Jordan Valley Medical Center is now utilizing ... for sudden cardiac arrest. When a patient wears this ... any life-threatening abnormalities. If an abnormal heart rhythm is ... a treatment shock to restore normal rhythm to the ... Medical Center and the Heart and Lung Institute of ...
Breaking Medicine News(10 mins):Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3
... study conducted by researchers say it is a misconception ... older or housebound people.// ,Researchers examined 150 ... levels of vitamin D. Among the participants, all African-American, ... D deficiencies, as were all patients younger than 30. ...
... A pitch-black room may be the healthiest environment for your ... at night // may put children at risk for ... to disrupt the circadian rhythm and suppress the production of ... been shown to protect DNA from oxidative damage. Once damaged, ...
... study shows sinusitis in asthma patients tends to be ... suggest patients // can have dramatic improvement in symptoms ... is used. ,In the study patients with asthma ... polyps, olfactory dysfunction, and nasal congestion compared to patients ...
... new study shows moderate consumption of alcohol may cut ... arteries.// Researchers evaluated 225 men after they had undergone ... open blocked arteries with a stent. Less traumatic than ... cause inflammation resulting in renarrowing of the artery, usually ...
... study researchers say the antidepressant duloxetine, also known ... fibromyalgia in women . Duloxetine works by stopping ... of the brain’s neurotransmitters that are linked to ... that is characterized by body pain, muscle tenderness, ...
... cluster of risk factors known as metabolic syndrome is ... risk factors. // ,Metabolic syndrome has been ... coronary heart disease. Metabolic syndrome includes looking at factors ... has two different definitions including one by the National ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: